Evidence map›Paper›PMID 33832539›Full record

ArticleActa neuropathologica communications2021

Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.

Marangelie Criado-Marrero, Niat T Gebru, Danielle M Blazier, Lauren A Gould, Jeremy D Baker, David Beaulieu-Abdelahad, Laura J Blair

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Marangelie Criado-Marrero *USF Health Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, 33613, USA.
Niat T Gebru *USF Health Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, 33613, USA.
Danielle M BlazierUSF Health Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, 33613, USA.
Lauren A GouldUSF Health Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, 33613, USA.
Jeremy D BakerUSF Health Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, 33613, USA.
David Beaulieu-AbdelahadUSF Health Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, 33613, USA.
Laura J BlairUSF Health Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, 33613, USA. laurablair@usf.edu.ORCID http://orcid.org/0000-0002-4981-5564
University of South Florida · US

Funding

The Hsp90 cochaperone FKBP51 regulates tau structure and functionR01NS073899 · NINDS · UNIVERSITY OF SOUTH FLORIDA · PI Laura J Blair · 2011 to 2026
$6.9M
Controlling tau toxicity from inside and outside of neuronsRF1AG055088 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI BICKFORD, PAULA C, BLAIR, LAURA J · 2017 to 2017
$2.3M
Modeling stress-related psychopathology through FKBP5 manipulationR01MH103848 · NIMH · UNIVERSITY OF SOUTH FLORIDA · PI BLAIR, LAURA J · 2014 to 2018
$1.9M
Controlling FKBP51 for the treatment of PTSDI01BX004626 · VA · JAMES A. HALEY VA MEDICAL CENTER · PI Laura J Blair · 2020 to 2026
–
BLRD VA I01 BX004626NIA NIH HHS RF1 AG055088NIMH NIH HHS R01 MH103848NINDS NIH HHS R01 NS073899
6 · The paper itself

Abstract

The microtubule associated protein tau is an intrinsically disordered phosphoprotein that accumulates under pathological conditions leading to formation of neurofibrillary tangles, a hallmark of Alzheimer's disease (AD). The mechanisms that initiate the accumulation of phospho-tau aggregates and filamentous deposits are largely unknown. In the past, our work and others' have shown that molecular chaperones play a crucial role in maintaining protein homeostasis and that imbalance in their levels or activity can drive tau pathogenesis. We have found two co-chaperones of the 90 kDa heat shock protein (Hsp90), FK506-binding protein 52 (FKBP52) and the activator of Hsp90 ATPase homolog 1 (Aha1), promote tau aggregation in vitro and in the brains of tau transgenic mice. Based on this, we hypothesized that increased levels of these chaperones could promote tau misfolding and accumulation in the brains of aged wild-type mice. We tested this hypothesis by overexpressing Aha1, FKBP52, or mCherry (control) proteins in the hippocampus of 9-month-old wild-type mice. After 7 months of expression, mice were evaluated for cognitive and pathological changes. Our results show that FKBP52 overexpression impaired spatial reversal learning, while Aha1 overexpression impaired associative learning in aged wild-type mice. FKBP52 and Aha1 overexpression promoted phosphorylation of distinct AD-relevant tau species. Furthermore, FKBP52 activated gliosis and promoted neuronal loss leading to a reduction in hippocampal volume. Glial activation and phospho-tau accumulation were also detected in areas adjacent to the hippocampus, including the entorhinal cortex, suggesting that after initiation these pathologies can propagate through other brain regions. Overall, our findings suggest a role for chaperone imbalance in the initiation of tau accumulation in the aging brain.

Indexed as

AnimalsBrainCognitive DysfunctionHSP90 Heat-Shock ProteinsMiceMolecular ChaperonesProtein Aggregation, PathologicalTacrolimus Binding ProteinsTauopathiestau ProteinsAhsa1 protein, mouseHSP90 Heat-Shock ProteinsMolecular Chaperonestacrolimus binding protein 4Tacrolimus Binding Proteinstau ProteinsAha1Alzheimer’s diseaseFKBP52Molecular chaperonesNeuroinflammationTau

Identifiers

PMID33832539
PMCPMC8033733
OpenAlexW3147722354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.